MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/liv.70557

Медицинская библиотека · Liver international : official journal of the International Association for the Study of the Liver · 2026

Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study.

Veyre Florian, Francoz Claire, Erard Domitille, DeMartin Eleonora, Elkrief Laure, Besch Camille, Boillot Olivier, Conti Filomena, Dharancy Sébastien, Duvoux Christophe, Gugenheim Jean, Hardwigsen Jean, Hilleret Marie-Noëlle, Leroy Vincent, Ollivier-Hourmand Isabelle, Gratien Marilyne, Houssel-Debry Pauline, Kamar Nassim, Roux Olivier, Hiriart Jean-Baptiste, Irles-Depe Marie, Pellegrin Sophie, Durand François, Pageaux Georges-Philippe, Faure Stéphanie, Coilly Audrey, Radenne Sylvie, Saliba Faouzi, Samuel Didier, Vanlemmens Claire, Latournerie Marianne, Boudjema Karim, Salamé Ephrem, Chazouillères Olivier, Corpechot Christophe, Dumortier Jérôme

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

A significant proportion of patients presenting a primary sclerosing cholangitis (PSC) will require liver transplantation (LT). The present study aimed to investigate graft loss and patient death in a large cohort of patients.

METHODS

We conducted a nationwide multicenter retrospective study including all adult patients transplanted for PSC in France From 1985 to 2019.

RESULTS

Were included 571 patients; median follow-up after LT was 89.0 months (IQR, 43.0-151.0). Patient survival at 5, 10 and 20 years after LT was 88.2%, 81.2% and 62.6%. After exclusion of patients who died during the first month after LT, 37 patients (6.6%) died during the first 2 years and the main cause was malignancies (n = 15, 40.5%, including 12 cases of recurrent cholangiocellular carcinoma). After 2 years, 90 patients (17.2%) died; the two main causes were malignancies (n = 36, 40.0%, including 13 cases of colorectal cancer) and sepsis (n = 23, 25.6%, of which 7 were related to recurrent PSC). Graft survival at 5, 10 and 20 years was 89.5%,78.7% and 62.7%. Independent factors associated with late patient death (after 2 years) were an older age at LT, a bilio-digestive anastomosis and the use of preventive UDCA; independent factors associated with late graft loss were recurrent PSC, cellular rejection, a younger age at LT, and the use of tacrolimus (protective).

CONCLUSIONS

Our results emphasise that the prognosis after LT for PSC could be improved by better detection of cholangiocellular carcinoma before LT, and colorectal cancer after LT.

Для цитирования: Veyre Florian, Francoz Claire, Erard Domitille, DeMartin Eleonora, Elkrief Laure, Besch Camille, Boillot Olivier, Conti Filomena, Dharancy Sébastien, Duvoux Christophe, Gugenheim Jean, Hardwigsen Jean, Hilleret Marie-Noëlle, Leroy Vincent, Ollivier-Hourmand Isabelle, Gratien Marilyne, Houssel-Debry Pauline, Kamar Nassim, Roux Olivier, Hiriart Jean-Baptiste, Irles-Depe Marie, Pellegrin Sophie, Durand François, Pageaux Georges-Philippe, Faure Stéphanie, Coilly Audrey, Radenne Sylvie, Saliba Faouzi, Samuel Didier, Vanlemmens Claire, Latournerie Marianne, Boudjema Karim, Salamé Ephrem, Chazouillères Olivier, Corpechot Christophe, Dumortier Jérôme. Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study.. Liver international : official journal of the International Association for the Study of the Liver. 2026. DOI: 10.1111/liv.70557.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.